Medical Cannabis Facilitates AIDS Treatment In Patients With Nausea, Study Says

Stanford, CA: Patients who use medicinal cannabis to combat the nausea associated with anti-HIV drugs are more likely to remain on their prescribed drug therapies than those who do not, according to clinical trial data published in the January issue of the Journal of Acquired Immune Deficiency Syndromes.

Researchers at Stanford University’s School of Medicine determined that among patients suffering from nausea associated with anti-retroviral therapy, those who used medical marijuana were 3.3 times more likely to adhere to their medication regimens than non-users.

“These data suggest that medicinal use of marijuana may facilitate, rather than impede, anti-retroviral therapy adherence for patients with nausea, in contrast to the use of other illicit substances, which was associated with decreased adherence,” authors concluded.

Researchers had previously presented their data in July at the XV International AIDS Conference in Bangkok, Thailand.

For more information, please contact either Allen St. Pierre or Paul Armentano of the NORML Foundation at (202) 483-5500. Abstracts of the study are available online at: